XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 57,599 $ 18,769
Adjustments to reconcile net income to net cash provided by operating activities -    
Depreciation, depletion and amortization 156,991 152,935
Amortization and write-off of debt issuance costs and discount 5,370 6,820
Amortization of unearned income and initial direct costs on direct financing leases (6,227) (6,615)
Payments received under direct financing leases 10,334 10,334
Equity in earnings of investments in equity investees (28,043) (18,896)
Cash distributions of earnings of equity investees 27,735 20,162
Non-cash effect of long-term incentive compensation plans 3,822 1,662
Deferred and other tax liabilities 335 331
Unrealized loss on derivative transactions 13,304 3,269
Other, net (7,703) (3,800)
Net changes in components of operating assets and liabilities (Note 14) (37,907) (34,155)
Net cash provided by operating activities 195,610 150,816
CASH FLOWS FROM INVESTING ACTIVITIES:    
Payments to acquire fixed and intangible assets (68,666) (110,970)
Cash distributions received from equity investees - return of investment 10,811 17,828
Investments in equity investees 0 (395)
Proceeds from asset sales 861 1,192
Net cash used in investing activities (56,994) (92,345)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings on senior secured credit facility 387,000 543,100
Repayments on senior secured credit facility (390,100) (336,000)
Repayment of senior unsecured notes 0 (145,170)
Debt issuance costs 0 (224)
Contributions from noncontrolling interests 1,230 1,320
Distributions to common unitholders (134,838) (126,257)
Distributions to preferred unitholders (6,138) 0
Other, net 3,509 3,565
Net cash used in financing activities (139,337) (59,666)
Net decrease in cash and cash equivalents (721) (1,195)
Cash and cash equivalents at beginning of period 10,300 9,041
Cash and cash equivalents at end of period $ 9,579 $ 7,846